Relevium Technologies Inc.

(RLV:CA)

By |

Investing in Active Lifestyles & Healthy Living

Relevium is a publicly traded corporation strategically focused in musculoskeletal function specifically in the areas of pain relief, recovery and performance enhancement.

The company’s first acquisition is a patented technology that helps the recovery process from musculoskeletal injuries. Musculoskeletal injuries and dysfunction represent a major source of economic burden on the medical systems of most developed countries. Musculoskeletal conditions are also a major cause of absence from work comprising the majority of all work-related illness.

Through its wholly-owned subsidiary Bioflex Technologies Inc., the company will focus on the development and commercialization of magnetic therapeutic devices to assist in the recovery and healing process from injuries in muscles, ligaments, tendons and nerves.

Our Focus

Pain Relief
pain relief

Recovery
recovery

Performance
performance

Pain avoidance is one of the most important drivers of consumer behavior worldwide. Pain relief currently represents a $31 billion market and expected to grow at a CAGR of 5% every year. The primary focus of Relevium in this vertical segment is on wearable devices that reduce musculoskeletal pain caused by injuries or mechanical dysfunction.

Musculoskeletal injuries such as sprains and strains are amongst the most common and costly burdens to the medical system and workforce. Direct and indirect costs are said to exceed $150 billion per year in Canada and the US alone. The primary focus of Relevium in this vertical segment is on wearable technologies that reduce recovery times in treating musculoskeletal injuries.

The global sports apparel market was worth over $135 billion in 2012. Growing fitness consciousness, rising income levels in developing countries and increasing popularity of sports apparel is expected to drive market growth at a CAGR of 4% per year. The primary focus of Relevium in this vertical segment is on wearable technologies that enhance athletic performance and reduce recovery time.

For more information please visit http://www.releviumcorp.com/

Additional Material


In the interest of full disclosure, we call the reader's attention to the fact that Equities.com, Inc. is compensated by the companies profiled in the Spotlight Companies section. The purpose of these profiles is to provide awareness of these companies to investors in the micro, small-cap and growth equity community and should not in any way be considered as a recommendation to buy, sell or hold these securities. Equities.com is not a registered broker dealer, investment advisor, financial analyst, investment banker or other investment professional. We are a publisher of original and third party news and information. All profiles are based on information that is available to the public. The information contained herein should not be considered to be complete and is not guaranteed by Equities.com to be free from misstatement or errors. The views expressed are our own and not intended to be the basis for any investment decision. Readers are reminded to do their own due diligence when researching any companies mentioned on this website. Always bear in mind that investing in early-stage companies is risky and you are encouraged to only invest an amount that you can afford to lose completely without any change in your lifestyle. Equities has been compensated with cash, common shares and/or warrants for market awareness services provided.


Relevium Technologies Inc.

Profile

Relevium Technologies Inc is engaged in the acquisition of products, technologies and businesses relating to musculoskeletal function, specifically Pain Relief, Injury Recovery and Active Performance.

Contact Information

Website: www.releviumcorp.com
Main Phone: +1 514 562-1374
Address: 3733 Cote Vertu
Address 2: Suite 350
State: QC
City / Town: Saint-Laurent
Country: CAN
Postal Code: H4R 2M3

Issuer Information

Exchange: CDX
CEO: Leena Lakdawala
Issuer Type: CS - Common Stock
Sector/Industry: Cyclical
NAICS: Ophthalmic Goods
$ 0.12 $ 0.01 (9.09%)
Last Price 0.12 Change $ 0.01 Change % 9.09 Tick N/A
Bid 0.11 Bid Size 147,000.00 Ask 0.12 Ask Size 31,500.00
Open 0.11 High 0.12 Low 0.11 Prev Close 0.11
Last Trade Volume 124,250 52 Wk Hi 0.22 52 Wk Low 0.04
Market Cap 4.2 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 34,783,966.00 EPS (TTM) -0.05 PE Ratio N/A Exchange TSXV